Financement 28.06.2023AMOEBA (FR0011051598 – ALMIB), producer of a biological biocide capable … Amoéba, one of the major players in French biotech, renews for the third time a financing line of up to 23 million euros with Nice & Green to support its developmentLire la suite
Financement 28.06.2023The Spanish technology company Facephi has just concluded a second … Facephi, a world leader in biometric solutions for identity verification, renews its contract with Nice & Green and obtains funding for 20 million euros to enhance its growth planLire la suite
Financement 28.06.2023Evolva (SIX:EVE), the Swiss biotech company focused on the research, … Evolva, the Swiss biotech company, researching, developing and commercializing nature-based ingredients, has renewed its trust in Nice & Green by securing another CHF 12 million investmentLire la suite
Financement 28.06.2023Bublar Group enters into a flexible convertible loan agreement with … Bublar Group enters into financing agreement of up to SEK 50.4 millionLire la suite
Financement 28.06.2023Artificial Solutions® International AB (publ) (“Artificial Solutions”) (SSME:ASAI) the leading … Artificial Solutions agrees a flexible convertible notes funding program providing up to SEK 60 million to support accelerated growthLire la suite
